These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25645535)

  • 21. Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.
    Vitaliti G; Pavone P; Mahmood F; Nunnari G; Falsaperla R
    Hum Vaccin Immunother; 2014; 10(4):868-75. PubMed ID: 24609096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroinflammatory targets and treatments for epilepsy validated in experimental models.
    Aronica E; Bauer S; Bozzi Y; Caleo M; Dingledine R; Gorter JA; Henshall DC; Kaufer D; Koh S; Löscher W; Louboutin JP; Mishto M; Norwood BA; Palma E; Poulter MO; Terrone G; Vezzani A; Kaminski RM
    Epilepsia; 2017 Jul; 58 Suppl 3(Suppl 3):27-38. PubMed ID: 28675563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of CNS inflammation and potential targets for anticonvulsants.
    Falip M; Salas-Puig X; Cara C
    CNS Drugs; 2013 Aug; 27(8):611-23. PubMed ID: 23771734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.
    Löscher W
    Seizure; 2011 Jun; 20(5):359-68. PubMed ID: 21292505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-mediated neuroprotection and antiepileptogenesis: animal data.
    Pitkänen A
    Neurology; 2002 Nov; 59(9 Suppl 5):S27-33. PubMed ID: 12428029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanism of action of antiepileptic drugs and new antiepileptic drugs].
    Armijo JA; Adin J; Sánchez MB
    Rev Neurol; 2006 Oct; 43 Suppl 1():S17-41. PubMed ID: 17061186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroinflammation impact in epileptogenesis and new treatment strategy.
    Mahfoz AM; Shahzad N
    Behav Pharmacol; 2019 Dec; 30(8):661-675. PubMed ID: 31658099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Astrocyte immune responses in epilepsy.
    Aronica E; Ravizza T; Zurolo E; Vezzani A
    Glia; 2012 Aug; 60(8):1258-68. PubMed ID: 22331574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances related to basic mechanisms of epileptogenesis.
    Lowenstein DH
    Epilepsy Res Suppl; 1996; 11():45-60. PubMed ID: 9294727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epilepsy: key experimental therapeutics in early clinical development.
    Steriade C; French J; Devinsky O
    Expert Opin Investig Drugs; 2020 Apr; 29(4):373-383. PubMed ID: 32172604
    [No Abstract]   [Full Text] [Related]  

  • 31. New visions in the pharmacology of anticonvulsion.
    Löscher W
    Eur J Pharmacol; 1998 Jan; 342(1):1-13. PubMed ID: 9544786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
    Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
    Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-epileptogenesis in rodent post-traumatic epilepsy models.
    Pitkänen A; Bolkvadze T; Immonen R
    Neurosci Lett; 2011 Jun; 497(3):163-71. PubMed ID: 21402123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation and prevention of epileptogenesis.
    Ravizza T; Balosso S; Vezzani A
    Neurosci Lett; 2011 Jun; 497(3):223-30. PubMed ID: 21362451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation microenvironment sharpens seizure circuit.
    Villasana-Salazar B; Vezzani A
    Neurobiol Dis; 2023 Mar; 178():106027. PubMed ID: 36736598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocytes as a target for therapeutic strategies in epilepsy: current insights.
    Çarçak N; Onat F; Sitnikova E
    Front Mol Neurosci; 2023; 16():1183775. PubMed ID: 37583518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Adenosine Kinase Inhibitor in Adenosine Augmentation Therapy for Epilepsy: A Potential Novel Drug for Epilepsy.
    Wang X; Li T
    Curr Drug Targets; 2020; 21(3):252-257. PubMed ID: 31633474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary prevention of epilepsy in patients with different epileptogenic conditions.
    Beghi E; Beghi M; Cornaggia C
    Expert Rev Neurother; 2004 Nov; 4(6):945-52. PubMed ID: 15853521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of inflammation and its miRNA based regulation in epilepsy: Implications for therapy.
    Srivastava A; Dixit AB; Banerjee J; Tripathi M; Sarat Chandra P
    Clin Chim Acta; 2016 Jan; 452():1-9. PubMed ID: 26506013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.